RXRX – Recursion Pharmaceuticals, Inc.
Name :
Sector :
Industry:
Mark. Cap: $0.0000
EPSttm :
Float Short %
22.77
Margin Of Safety %
Put/Call OI Ratio
0.3
EPS Next Q Diff
-0.14
EPS Last/This Y
0.04
EPS This/Next Y
-0.11
Price
6.52
Target Price
9.17
Analyst Recom
2.43
Performance Q
-6.85
Relative Volume
0.82
Beta
0.85
Ticker: RXRX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-12-19 | RXRX | 6.08 | 0.35 | 0.35 | 235333 |
| 2024-12-20 | RXRX | 6.04 | 0.35 | 0.49 | 238848 |
| 2024-12-23 | RXRX | 7 | 0.32 | 0.17 | 190153 |
| 2024-12-24 | RXRX | 7.24 | 0.31 | 0.18 | 207095 |
| 2024-12-26 | RXRX | 7.62 | 0.31 | 0.16 | 210837 |
| 2024-12-27 | RXRX | 7.4 | 0.31 | 0.22 | 213862 |
| 2024-12-30 | RXRX | 6.76 | 0.32 | 0.30 | 203968 |
| 2024-12-31 | RXRX | 6.77 | 0.32 | 0.14 | 208946 |
| 2025-01-02 | RXRX | 7.21 | 0.32 | 0.25 | 212431 |
| 2025-01-03 | RXRX | 7.77 | 0.32 | 0.15 | 220693 |
| 2025-01-06 | RXRX | 7.95 | 0.33 | 0.20 | 208539 |
| 2025-01-07 | RXRX | 7.48 | 0.33 | 0.16 | 213704 |
| 2025-01-08 | RXRX | 7.26 | 0.32 | 0.26 | 224629 |
| 2025-01-09 | RXRX | 7.26 | 0.32 | 0.26 | 224629 |
| 2025-01-10 | RXRX | 6.92 | 0.31 | 0.29 | 225512 |
| 2025-01-13 | RXRX | 6.74 | 0.32 | 0.26 | 212881 |
| 2025-01-14 | RXRX | 6.32 | 0.31 | 0.24 | 217900 |
| 2025-01-15 | RXRX | 6.42 | 0.31 | 0.19 | 227329 |
| 2025-01-16 | RXRX | 6.42 | 0.31 | 0.40 | 235097 |
| 2025-01-17 | RXRX | 6.52 | 0.30 | 0.27 | 239224 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-12-19 | RXRX | 6.08 | 1.7 | - | -1.54 |
| 2024-12-20 | RXRX | 6.04 | 1.7 | - | -1.54 |
| 2024-12-23 | RXRX | 6.99 | 1.7 | - | -1.54 |
| 2024-12-24 | RXRX | 7.24 | 1.7 | - | -1.54 |
| 2024-12-26 | RXRX | 7.66 | 1.7 | - | -1.54 |
| 2024-12-27 | RXRX | 7.40 | 1.7 | - | -1.54 |
| 2024-12-30 | RXRX | 6.77 | 1.7 | - | -1.54 |
| 2024-12-31 | RXRX | 6.75 | 1.7 | - | -1.54 |
| 2025-01-02 | RXRX | 7.21 | 1.7 | - | -1.54 |
| 2025-01-03 | RXRX | 7.78 | 1.7 | - | -1.54 |
| 2025-01-06 | RXRX | 7.94 | 1.7 | - | -1.54 |
| 2025-01-07 | RXRX | 7.49 | 1.7 | - | -1.54 |
| 2025-01-08 | RXRX | 7.26 | 1.7 | - | -1.54 |
| 2025-01-09 | RXRX | 7.26 | 1.7 | - | -1.54 |
| 2025-01-10 | RXRX | 6.88 | 1.7 | - | -1.54 |
| 2025-01-13 | RXRX | 6.75 | 1.7 | - | -1.54 |
| 2025-01-14 | RXRX | 6.32 | 1.7 | - | -1.54 |
| 2025-01-15 | RXRX | 6.42 | 1.7 | - | -1.54 |
| 2025-01-16 | RXRX | 6.41 | 1.7 | - | -1.54 |
| 2025-01-17 | RXRX | 6.52 | 1.7 | - | -1.54 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-12-19 | RXRX | -0.92 | 5.15 | 21.03 |
| 2024-12-20 | RXRX | -0.92 | 5.15 | 21.03 |
| 2024-12-23 | RXRX | -0.93 | 2.73 | 20.95 |
| 2024-12-24 | RXRX | -0.92 | 2.73 | 20.95 |
| 2024-12-26 | RXRX | -0.88 | 2.73 | 20.72 |
| 2024-12-27 | RXRX | -0.91 | 2.73 | 20.74 |
| 2024-12-30 | RXRX | -0.91 | 2.66 | 20.74 |
| 2024-12-31 | RXRX | -0.91 | 2.66 | 20.74 |
| 2025-01-02 | RXRX | -0.88 | 2.66 | 20.74 |
| 2025-01-03 | RXRX | -0.88 | 2.66 | 20.74 |
| 2025-01-06 | RXRX | -0.82 | 2.49 | 20.74 |
| 2025-01-07 | RXRX | -0.82 | 2.49 | 20.74 |
| 2025-01-08 | RXRX | -0.88 | 2.49 | 20.74 |
| 2025-01-09 | RXRX | -0.88 | 2.49 | 20.74 |
| 2025-01-10 | RXRX | -0.88 | 2.49 | 20.74 |
| 2025-01-13 | RXRX | -0.68 | 2.32 | 22.79 |
| 2025-01-14 | RXRX | -0.73 | 2.32 | 22.79 |
| 2025-01-15 | RXRX | -0.73 | 2.32 | 22.79 |
| 2025-01-16 | RXRX | -0.73 | 2.32 | 22.79 |
| 2025-01-17 | RXRX | -0.74 | 2.32 | 22.77 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.34
Avg. EPS Est. Current Quarter
-0.41
Avg. EPS Est. Next Quarter
-0.48
Insider Transactions
-0.74
Institutional Transactions
2.32
Beta
0.85
Average Sales Estimate Current Quarter
18
Average Sales Estimate Next Quarter
12
Fair Value
Quality Score
31
Growth Score
49
Sentiment Score
2
Actual DrawDown %
84.8
Max Drawdown 5-Year %
Target Price
9.17
P/E
Forward P/E
PEG
P/S
39.15
P/B
3.56
P/Free Cash Flow
EPS
-1.53
Average EPS Est. Cur. Y
-1.54
EPS Next Y. (Est.)
-1.65
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-579.51
Relative Volume
0.82
Return on Equity vs Sector %
-91.1
Return on Equity vs Industry %
-78.5
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
0.02
EBIT Estimation
stock quote shares RXRX – Recursion Pharmaceuticals, Inc. Stock Price stock today
news today RXRX – Recursion Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RXRX – Recursion Pharmaceuticals, Inc. yahoo finance google finance
stock history RXRX – Recursion Pharmaceuticals, Inc. invest stock market
stock prices RXRX premarket after hours
ticker RXRX fair value insiders trading